References
- Aiello, R. J., P.-A. K. Bourassa, S. Lindsey, W. Weng, E. Natoli, B. J. Rollins, and P. M. Milos. 1999. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19: 1518-1525. https://doi.org/10.1161/01.ATV.19.6.1518
- Allain, C. C., L. S. Poon, C. S. G. Chan, W. Richmond, and P. C. Fu. 1974. Enzymatic determination of total serum cholesterol. Clin. Chem. 20: 470-475.
- Bhatia, L. S., N. P. Curzen, P. C. Calder, and C. D. Byrne.2012. Non-alcoholic fatty liver disease: A new and important cardiovascular risk factor? Eur. Heart J. 33: 1190-2000. https://doi.org/10.1093/eurheartj/ehr453
- Brea, A., D. Mosquera, E. Martín, A. Arizti, J. L. Cordero, and E. Ros. 2005. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: A case-control study. Arterioscler. Thromb. Vasc. Biol. 25: 1045-1050. https://doi.org/10.1161/01.ATV.0000160613.57985.18
- Bucolo, G. and H. David. 1973. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 19:476-482.
- Carallo, C., G. Mancuso, G. Mauro, F. Laghi, B. Madafferi, C. Irace, et al. 2009. Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: The STEATO Study. J. Gastroenterol. 44: 1156-1161. https://doi.org/10.1007/s00535-009-0125-8
- Charo, I. F. and M. B. Taubman. 2004. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95: 858-866. https://doi.org/10.1161/01.RES.0000146672.10582.17
- Chee, M., R. Yang, E. Hubbell, A. Berno, X. C. Huang, D. Stern, et al. 1996. Accessing genetic information with highdensity DNA arrays. Science 274: 610-614. https://doi.org/10.1126/science.274.5287.610
- Decorde, K., E. Ventura, D. Lacan, J. Ramos, J. P. Cristol, and J. M. Rouanet. 2010. An SOD rich melon extract Extramel prevents aortic lipids and liver steatosis in diet-induced model of atherosclerosis. Nutr. Metab. Cardiovasc. Dis. 20: 301-307. https://doi.org/10.1016/j.numecd.2009.04.017
- Erdely, A., D. Kepka-Lenhart, R. Salmen-Muniz, R. Chapman, T. Hulderman, M. Kashon, et al. 2010. Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: Responses to high fat and high cholesterol diets. PLoS One 5: e15253. https://doi.org/10.1371/journal.pone.0015253
- Fong, L. G., T. A. Fong, and A. D. Cooper. 1991. Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein. J. Lipid Res. 32: 1899-1910.
- Getz, G. S. and C. A. Reardon. 2006. Diet and murine atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26: 242-249.
- Gosling, J., S. Slaymaker, L. Gu, S. Tseng, C. H. Zlot, S. G. Young, et al. 1999. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103: 773-778. https://doi.org/10.1172/JCI5624
- Gu, L., Y. Okada, S. K. Clinton, C. Gerard, G. K. Sukhova, P. Libby, and B. J. Rollins. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2: 275-281. https://doi.org/10.1016/S1097-2765(00)80139-2
- Gupte, A. A., J. Z. Liu, Y. Ren, L. J. Minze, J. R. Wiles, A. R. Collins, et al. 2010. Rosiglitazone attenuates age- and dietassociated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. Hepatology 52: 2001-2011. https://doi.org/10.1002/hep.23941
- Hamilton, T. A., J. A. Major, and G. M. Chisolm. 1995. The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J. Clin. Invest. 95: 2020-2027. https://doi.org/10.1172/JCI117887
- Ishigaki, Y., H. Katagiri, J. Gao, T. Yamada, J. Imai, K. Uno, et al. 2008. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation 118: 75-83. https://doi.org/10.1161/CIRCULATIONAHA.107.745174
- Jang, M. K., J. Y. Kim, N. H. Jeoung, M. A. Kang, M. S. Choi, and Y. B. Park. 2004. Oxidized low-density lipoproteins may induce expression of monocyte chemotactic protein-3 in atherosclerotic plaques. Biochem. Biophys. Res. Commun. 323:898-905. https://doi.org/10.1016/j.bbrc.2004.08.178
- Kim, H. J., G. T. Oh, Y. B. Park, M. K. Lee, H. J. Seo, and M. S. Choi. 2004. Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition. Life Sci. 74: 1621-1634. https://doi.org/10.1016/j.lfs.2003.08.026
- Lichtman, A. H., S. K. Clinton, K. Iiyama, P. W. Connelly, P. Libby, and M. I. Cybulsky. 1999. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semi-purified diets with and without cholate. Arterioscler. Thromb. Vasc. Biol. 19: 1938-1944. https://doi.org/10.1161/01.ATV.19.8.1938
- Malden, L. T., A. Chait, E. W. Raines, and R. Ross. 1991. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocytederived macrophages. J. Biol. Chem. 266: 13901-13907.
- Murdoch, C. and A. Finn. 2000. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032-3043.
- Nagy, L., P. Tontonoz, J. G. A. Alvarez, H. Chen, and R. M. Evans. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR. Cell 93: 229-240. https://doi.org/10.1016/S0092-8674(00)81574-3
- Nelken, N. A., S. R. Coughlin, D. Gordon, and J. N. Wilcox. 1991. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88: 1121-1127. https://doi.org/10.1172/JCI115411
- Parks, E. J. and E. J. Parks. 2002. Changes in fat synthesis influenced by dietary macronutrient content. Proc. Nutr. Soc.61: 281-286. https://doi.org/10.1079/PNS2002148
-
Ricote, M., J. Huang, and L. Fajas. 1998. Expression of the peroxisome proliferator-activated receptor
$\gamma$ (PPAR$\gamma$ ) in human atherosclerosis and regulation in macrophage by colony stimulating factor and oxidized low-density lipoprotein. Proc. Natl. Acad. Sci. USA 95: 7614-7619 https://doi.org/10.1073/pnas.95.13.7614 - Samson, S., L. Mundkur, and V. V. Kakkar. 2012. Immune response to lipoproteins in atherosclerosis. Cholesterol. DOI:10.1155/2012/571846.
- Schena, M., D. Shalon, R. W. Davis, and P. O. Brown. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470. https://doi.org/10.1126/science.270.5235.467
- Shankar, K., A. Harrell, P. Kang, R. Singhal, M. J. Ronis, and T. M. Badger. 2010. Carbohydrate-responsive gene expression in the adipose tissue of rats. Endocrinology 151: 153-164. https://doi.org/10.1210/en.2009-0840
- Teodoro, B. G., A. J. Natali, S. A. Fernandes, L. A. Silva, R. A. Pinho, S. L. Matta, and M. D. Peluzio. 2012. Improvements of atherosclerosis and hepatic oxidative stress are independent of exercise intensity in LDLr(-/-) mice. J. Atheroscler. Thromb. 19: 904-911. https://doi.org/10.5551/jat.11569
- Tous, M., N. Ferre, J. Camps, F. Riu, and J. Joven. 2005. Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol. Cell. Biochem. 268: 53-58. https://doi.org/10.1007/s11010-005-2997-0
- Tsou, C. L., W. Peters, Y. Si, S. Slaymaker, A. M. Aslanian, S. P. Weisberg, et al. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117: 902-909. https://doi.org/10.1172/JCI29919
-
Warnick, J. B., J. Benderson, and J. J. Albers. 1982. HDL precipitation by dextran sulfate-
$MgCl_{2}$ method. Clin. Chem. 28: 1397-1382. - Weber, C., A. Zernecke, and P. Libby. 2008. The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models. Nat. Rev. Immunol. 8: 802-815. https://doi.org/10.1038/nri2415
- Yang, Y. H., S. Dudoit, P. Luu, D. M. Lin, V. Peng, J. Ngai, and T. P. Speed. 2002. Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30: e15. https://doi.org/10.1093/nar/30.4.e15
- Zhang, S., X. Wang, L. Zhang, X. Yang, J. Pan, and G. Ren. 2011. Characterization of monocyte chemoattractant proteins and CC chemokine receptor 2 expression during atherogenesis in apolipoprotein E-null mice. J. Atheroscler. Thromb. 18: 846-856. https://doi.org/10.5551/jat.7211
Cited by
- 복분자 유래 성분 protocatechuic acid 투여가 고콜레스테롤 식이로 유도된 생쥐의 지질대사에 미치는 영향 vol.27, pp.4, 2014, https://doi.org/10.7732/kjpr.2014.27.4.271
- Tissue factor pathway inhibitor gene transfer prevents vascular smooth muscle cell proliferation by interfering with the MCP-3/CCR2 pathway vol.95, pp.11, 2013, https://doi.org/10.1038/labinvest.2015.106
- CCL7 contributes to the TNF‐alpha‐dependent inflammation of lesional psoriatic skin vol.24, pp.7, 2013, https://doi.org/10.1111/exd.12709
- The Potential of Fluocinolone Acetonide to Mitigate Inflammation and Lipid Accumulation in 2D and 3D Foam Cell Cultures vol.2018, pp.None, 2013, https://doi.org/10.1155/2018/3739251
- Hesperidin: A Therapeutic Agent For Obesity vol.13, pp.None, 2013, https://doi.org/10.2147/dddt.s227499
- Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression vol.10, pp.None, 2013, https://doi.org/10.1038/s41598-020-62596-6
- Transcription Factor MAFF (MAF Basic Leucine Zipper Transcription Factor F) Regulates an Atherosclerosis Relevant Network Connecting Inflammation and Cholesterol Metabolism vol.143, pp.18, 2013, https://doi.org/10.1161/circulationaha.120.050186
- Promoting plaque stability by gene silencing of monocyte chemotactic protein-3 or overexpression of tissue factor pathway inhibitor in ApoE-/- mice vol.29, pp.6, 2021, https://doi.org/10.1080/1061186x.2021.1878363